JOURNAL OF THE CZECH PEDIATRIC SOCIETY AND THE SLOVAK PEDIATRIC SOCIETY

Čes-slov Pediat 2023, 78(88):7-12 | DOI: 10.55095/CSPediatrie2023/026

Vaccination of children against COVID-19Comprehensive Report

Hana Cabrnochová1, 2
1 Očkovací centrum pro děti, Pediatrická klinika, 1. lékařská fakulta Univerzity Karlovy, Fakultní Thomayerova nemocnice, Praha
2 Ordinace PLDD, Praha 4

The risk of severe covid-19 is lower than in adults, most cases of covid-19 in children are asymptomatic or mild. With regard to the number of reported cases in children, we may encounter complicated cases, the need for hospitalization and intensive care stays. A rare complication of covid-19 in children is a multisystem inflammatory disease (referred to as MIS-C or PIMS-TS), which arises as a post- infectious complication of covid-19. As an additional complication in children, long-term problems called "long-covid" may occur after the disease. Vaccination against covid-19 is recommended for all children, in case of illness vaccination is not contraindicated, it is possible to postpone it for 3-6 months after the disease. Neither natural infection nor vaccination provides long-term immunity Vaccination can reduce the risk of reinfection and, above all, severe courses of the disease. Vaccination against covid-19 is indicated for all children aged 6 months and over, infants younger than 6 months can be protected by vaccinating the mother during pregnancy In childhood, mRNA vaccines are predominantly used. Their safety has been unequivocally proven. Billions of adults were vaccinated before childhood vaccination began, and millions of children are now safely vaccinated. In the Czech Republic, vaccination coverage in children reached 49.1% in the age category 12-15 years and 7.1% in the age category 5-11 years (administration of at least one dose of vaccine) as of 27.10.2022. The vaccination rate for the age category of children 12-17 years was 54.3% as of 15.2.2023, while for the youngest children 5-11 years the number remains the same as at the end of 2022.

Keywords: COVID-19 in children, vaccination of children, vaccines, adverse effects of vaccination, safety, efficacy, contraindications.

Accepted: June 22, 2023; Published: June 23, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cabrnochová H. Vaccination of children against COVID-19. Ces-slov Pediat. 2023;78(Suppl.1):7-12. doi: 10.55095/CSPediatrie2023/026.
Download citation

References

  1. Wang L, Berger NA, Kaelber DC, et al. Incidence rates and clinical outcomes of SARS-CoV-2 infection with the omicron and delta variants in children younger than 5 years in the US. JAMA Pediatr 2022; 176(8): 811-813. Go to original source... Go to PubMed...
  2. Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 2021; 268: 3059-3071. Go to original source... Go to PubMed...
  3. Antoon JW, Hall M, Howard LM, et al. COVID-19 and acute neurologic complications in children. Pediatrics 2022; 150. Go to original source... Go to PubMed...
  4. David J, Hradsky O, Jabandziev P, et al. Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS). J Paediatr Child Health 2022; 58(10): 1901-1903. Go to original source... Go to PubMed...
  5. Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep 2022; 12(1): 9950. Go to original source... Go to PubMed...
  6. Gottesman BL, Yu J, Tanaka C, et al. Incidence of new-onset type 1 diabetes among US children during the COVID-19 global pandemic. JAMA Pediatr 2022; 176: 414-415. Go to original source... Go to PubMed...
  7. Ministerstvo zdravotnictví České republiky. Onemocnění aktuálně - COVID-19. Datové sady. [online]. 2023. Dostupné z: https://onemocneni-aktualne.mzcr.cz/api/v2/covid-19
  8. Flaxman S, Whittaker C, Semenova E, et al. Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US. JAMA Netw Open 2023; 6(1): e2253590. Go to original source... Go to PubMed...
  9. Khan FL, Nguyen JL, Singh TG, et al. Estimated BNT162b2 vaccine effectiveness against infection with delta and omicron variants among US children 5 to 11 years of age. JAMA Netw Open 2022; 5: e2246915-e2246915. Go to original source... Go to PubMed...
  10. Mallapaty S. COVID jabs for kids: they're safe and they work - so why is uptake so patchy? Nature 2022; 610: 246-8. Go to original source... Go to PubMed...
  11. Castelli JM, Rearte A, Olszevicki S, et al. Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality inchildren in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study. BMJ 2022; 379. Go to original source... Go to PubMed...
  12. Chemaitelly H, AlMukdad S, Ayoub HH, et al. Covid-19 vaccine protection among children and adolescents in Qatar. N Engl J Med 2022; 387: 1865-1876. Go to original source... Go to PubMed...
  13. Holm M, Espenhain L, Glenthøj J, et al. Risk and phenotype of multisystem inflammatory syndrome in vaccinated and unvaccinated danish children before and during the omicron wave. JAMA Pediatr 2022; 176: 821-823. Go to original source... Go to PubMed...
  14. Lai FTT, Chan EWW, Huang L, et al. Prognosis of myocarditis developing after mRNA COVID-19 vaccination compared with viral myocarditis. J Am Coll Cardiol 2022; 80: 2255-2265. Go to original source... Go to PubMed...
  15. Elias MD, Truong DT, Oster ME, et al. Examination of adverse reactions after COVID-19 vaccination among patients with a history of multisystem inflammatory syndrome in children. JAMA Netw Open 2023; 6: e2248987-e2248987. Go to original source... Go to PubMed...
  16. Gruber WC, Jansen KU; C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021; 385(19): 1761-1773. Go to original source... Go to PubMed...
  17. Anderson EJ, Creech CB, Berthaud V, et al. Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age. N Engl J Med 2022; 387: 1673-1687. Go to original source... Go to PubMed...
  18. Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age. Dostupné z: www.pfizer.com
  19. ČVS. Doporučení České vakcinologické společnosti ČLS JEP k očkování proti onemocnění covid-19 (11/2022). 2022. Dostupné z: https://www.vakcinace.eu
  20. Ministerstvo zdravotnictví ČR. Dostupné z: https://www.mzcr.cz/tiskove-centrum-mz/denni-prehled-dat-k-ockovani-proti-covid-19-k-15-2-2023
  21. ECDC. Dostupné z: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-vaccination-strategies-march-2023.pdf

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.